Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 1,000
- Avg volume
- —
- Day's range
- $0.08 – $0.08
- Shares out
- —
- Stochastic %K
- —
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
Nirvana Life Sciences Inc. engages in the research and development of therapeutic products and medicines to address addiction. It also provides gel caps transition from opioids to non-addictive pain relief therapies. The company is headquartered in Vancouver, Canada.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 604 401 8100
- Website
- https://nirvanalifescience.com
- Address
- 650 West Georgia Street, Suite 2100, Vancouver, Canada
Latest news
No headlines yet.
